0935 GMT - Fresenius's sale of a portion of its stake in Fresenius Medical Care is a positive step that gives the former a source of funds to reduce debt and continue its strategy, Jefferies analysts say in a research note. German healthcare company Fresenius's 32.2% stake in Fresenius Medical Care has loomed over both companies, according to Jefferies. Fresenius cut its stake in the dialysis business to just above 25% by selling a 3.6% stake and a 600 million-euro bond exchangeable for an additional 3.5% stake, raising 1.1 billion euros in total. Shares in Fresenius Medical Care drop 7.1% to 44.10 euros, below the 44.50 euro level at which Fresenius sold the stake. Fresenius shares fall 0.6%. (adria.calatayud@wsj.com)
(END) Dow Jones Newswires
March 04, 2025 04:35 ET (09:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。